Skip to main content
Fig. 1 | Lipids in Health and Disease

Fig. 1

From: The beneficial effects of nutraceuticals and natural products on small dense LDL levels, LDL particle number and LDL particle size: a clinical review

Fig. 1

Schematic summary of pathways of endogenous lipid metabolism and pathways of the atherogenic and anti-atherogenic lipoproteins. sdLDL: small dense low density lipoprotein, Apo: apolipoprotein, VLDL: very-low-density lipoprotein, IDL: intermediate-density lipoprotein, LDL: low-density lipoprotein; LDL-R: low-density lipoprotein receptor, HDL: high-density lipoprotein, TG: triglycerides, CE: cholesteryl esters, +: increased risk

Back to article page

Lipids in Health and Disease

ISSN: 1476-511X